• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量和建模系统不遵守大规模药物给药的影响。

Measuring and modelling the effects of systematic non-adherence to mass drug administration.

机构信息

Mathematics Institute, University of Warwick, Coventry, UK; School of Life Sciences, University of Warwick, Coventry, UK.

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Epidemics. 2017 Mar;18:56-66. doi: 10.1016/j.epidem.2017.02.002.

DOI:10.1016/j.epidem.2017.02.002
PMID:28279457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5340860/
Abstract

It is well understood that the success or failure of a mass drug administration campaign critically depends on the level of coverage achieved. To that end coverage levels are often closely scrutinised during campaigns and the response to underperforming campaigns is to attempt to improve coverage. Modelling work has indicated, however, that the quality of the coverage achieved may also have a significant impact on the outcome. If the coverage achieved is likely to miss similar people every round then this can have a serious detrimental effect on the campaign outcome. We begin by reviewing the current modelling descriptions of this effect and introduce a new modelling framework that can be used to simulate a given level of systematic non-adherence. We formalise the likelihood that people may miss several rounds of treatment using the correlation in the attendance of different rounds. Using two very simplified models of the infection of helminths and non-helminths, respectively, we demonstrate that the modelling description used and the correlation included between treatment rounds can have a profound effect on the time to elimination of disease in a population. It is therefore clear that more detailed coverage data is required to accurately predict the time to disease elimination. We review published coverage data in which individuals are asked how many previous rounds they have attended, and show how this information may be used to assess the level of systematic non-adherence. We note that while the coverages in the data found range from 40.5% to 95.5%, still the correlations found lie in a fairly narrow range (between 0.2806 and 0.5351). This indicates that the level of systematic non-adherence may be similar even in data from different years, countries, diseases and administered drugs.

摘要

众所周知,大规模药物治疗运动的成败取决于所达到的覆盖率水平。为此,在运动期间通常会密切监测覆盖率水平,如果发现覆盖率不达标,就会尝试提高覆盖率。然而,建模工作表明,所达到的覆盖率质量也可能对结果产生重大影响。如果每次治疗都有可能遗漏相似的人,那么这可能会对运动结果产生严重的不利影响。我们首先回顾当前对这种影响的建模描述,并引入一个新的建模框架,该框架可用于模拟给定水平的系统不依从性。我们用不同轮次的就诊之间的相关性来形式化人们可能错过几个轮次治疗的可能性。我们分别使用两种非常简化的蠕虫和非蠕虫感染模型来演示,建模描述的使用以及治疗轮次之间包含的相关性可能对人群中疾病消除的时间产生深远影响。因此,很明显,需要更详细的覆盖率数据来准确预测疾病消除的时间。我们回顾了已发表的覆盖率数据,这些数据询问了个体之前参加过多少轮治疗,并展示了如何利用这些信息来评估系统不依从的程度。我们注意到,尽管数据中的覆盖率范围从 40.5%到 95.5%不等,但发现的相关性仍在相当窄的范围内(在 0.2806 到 0.5351 之间)。这表明即使在来自不同年份、国家、疾病和给药药物的数据中,系统不依从的程度可能也相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/f2c03966e71f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/cfda4f036f2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/26036ecf45c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/a4d8e41742bc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/7f0135ce96aa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/f2c03966e71f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/cfda4f036f2c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/26036ecf45c8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/a4d8e41742bc/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/7f0135ce96aa/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d0b/5340860/f2c03966e71f/gr6.jpg

相似文献

1
Measuring and modelling the effects of systematic non-adherence to mass drug administration.测量和建模系统不遵守大规模药物给药的影响。
Epidemics. 2017 Mar;18:56-66. doi: 10.1016/j.epidem.2017.02.002.
2
The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission.患者依从性在反复进行大规模药物给药(MDA)以消除肠道蠕虫传播中的重要性。
Parasit Vectors. 2017 Jun 12;10(1):291. doi: 10.1186/s13071-017-2206-5.
3
Helminth lifespan interacts with non-compliance in reducing the effectiveness of anthelmintic treatment.寄生虫寿命与不遵守规定相互作用,降低了驱虫治疗的效果。
Parasit Vectors. 2018 Jan 31;11(1):66. doi: 10.1186/s13071-018-2670-6.
4
Forecasting the effectiveness of the DeWorm3 trial in interrupting the transmission of soil-transmitted helminths in three study sites in Benin, India and Malawi.预测 Deworm3 试验在阻断贝宁、印度和马拉维三个研究点的土壤传播性蠕虫传播中的效果。
Parasit Vectors. 2021 Jan 20;14(1):67. doi: 10.1186/s13071-020-04572-7.
5
Coverage evaluation surveys following soil-transmitted helminthiasis and schistosomiasis mass drug administration in Wolaita Zone of Ethiopia-The Geshiyaro project.埃塞俄比亚沃莱塔地区土壤传播性蠕虫病和血吸虫病大规模药物治疗后的覆盖评估调查——Geshiyaro 项目。
PLoS One. 2021 Dec 21;16(12):e0260722. doi: 10.1371/journal.pone.0260722. eCollection 2021.
6
Patterns of individual compliance with anthelmintic treatment for soil-transmitted helminth infections in southern Ethiopia over six rounds of community-wide mass drug administration.在埃塞俄比亚南部,经过六轮社区范围的大规模药物驱虫治疗,个体对驱虫治疗的依从性模式。
Trans R Soc Trop Med Hyg. 2024 May 1;118(5):304-312. doi: 10.1093/trstmh/trad079.
7
Modelling the ability of mass drug administration to interrupt soil-transmitted helminth transmission: Community-based deworming in Kenya as a case study.建模大规模药物驱虫在中断土壤传播性蠕虫传播中的作用:肯尼亚社区驱虫作为案例研究。
PLoS Negl Trop Dis. 2021 Aug 2;15(8):e0009625. doi: 10.1371/journal.pntd.0009625. eCollection 2021 Aug.
8
Barriers and gaps in utilization and coverage of mass drug administration program against soil-transmitted helminth infection in Bangladesh: An implementation research.孟加拉国大规模驱虫药物方案在利用和覆盖方面存在的障碍和差距:实施研究。
J Infect Public Health. 2019 Mar-Apr;12(2):205-212. doi: 10.1016/j.jiph.2018.10.002. Epub 2018 Oct 29.
9
Defining stopping criteria for ending randomized clinical trials that investigate the interruption of transmission of soil-transmitted helminths employing mass drug administration.定义以大规模药物治疗来中断土壤传播性蠕虫传播的随机临床试验的停止标准。
PLoS Negl Trop Dis. 2018 Oct 1;12(10):e0006864. doi: 10.1371/journal.pntd.0006864. eCollection 2018 Oct.
10
Spatiotemporal distribution and population at risk of soil-transmitted helminth infections following an eight-year school-based deworming programme in Burundi, 2007-2014.2007-2014 年布隆迪开展为期八年的学校驱虫项目后,土壤传播性蠕虫感染的时空分布和高危人群。
Parasit Vectors. 2017 Nov 23;10(1):583. doi: 10.1186/s13071-017-2505-x.

引用本文的文献

1
High Levels of Community Support for Mansonellosis Interventions in an Endemic Area of the Brazilian Amazon.巴西亚马逊地区流行区对曼氏丝虫病干预措施的社区支持度较高。
Trop Med Infect Dis. 2025 Jul 2;10(7):186. doi: 10.3390/tropicalmed10070186.
2
How improvements to drug effectiveness impact mass drug administration for control and elimination of schistosomiasis.药物有效性的提高如何影响用于控制和消除血吸虫病的群体药物给药。
PLoS Negl Trop Dis. 2025 Jun 2;19(6):e0012624. doi: 10.1371/journal.pntd.0012624. eCollection 2025 Jun.
3
Population-level impact of mass drug administration against schistosomiasis with anthelmintic drugs targeting juvenile schistosomes: a modelling study.

本文引用的文献

1
The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission.患者依从性在反复进行大规模药物给药(MDA)以消除肠道蠕虫传播中的重要性。
Parasit Vectors. 2017 Jun 12;10(1):291. doi: 10.1186/s13071-017-2206-5.
2
Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.利用微观叙事调查提高印度尼西亚两个“收官”地区大规模药物管理的覆盖率和依从性以消除淋巴丝虫病
PLoS Negl Trop Dis. 2016 Nov 3;10(11):e0005027. doi: 10.1371/journal.pntd.0005027. eCollection 2016 Nov.
3
使用针对幼年血吸虫的驱虫药物进行群体药物管理对血吸虫病的人群水平影响:一项建模研究
Lancet Microbe. 2025 Jul;6(7):101065. doi: 10.1016/j.lanmic.2024.101065. Epub 2025 May 21.
4
Mass drug administration coverage and its determinants for the elimination of onchocerciasis in Ulanga District, Tanzania.坦桑尼亚乌兰加区大规模药物管理覆盖情况及其对盘尾丝虫病消除工作的决定因素
PLoS Negl Trop Dis. 2025 Apr 15;19(4):e0012219. doi: 10.1371/journal.pntd.0012219. eCollection 2025 Apr.
5
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in Cameroon between 1971 and 2020.1971年至2020年喀麦隆盘尾丝虫病患病率的基于模型的地质统计学绘图
PLoS Negl Trop Dis. 2025 Mar 28;19(3):e0012250. doi: 10.1371/journal.pntd.0012250. eCollection 2025 Mar.
6
Factors influencing participation of elderly population in mass drug administration for lymphatic filariasis: a cross-sectional study.影响老年人群参与淋巴丝虫病群体服药的因素:一项横断面研究。
Front Pharmacol. 2024 Nov 6;15:1429653. doi: 10.3389/fphar.2024.1429653. eCollection 2024.
7
Understanding the barriers and facilitators related to never treatment during mass drug administration among mobile and migrant populations in Mali: a qualitative exploratory study.了解马里流动人口和移民群体在大规模药物治疗期间不接受治疗的障碍和促进因素:一项定性探索性研究。
BMJ Glob Health. 2024 Oct 9;9(10):e015671. doi: 10.1136/bmjgh-2024-015671.
8
Dose-Dependent Prophylactic Efficacy of Filarial Antigens Glutathione-S-Transferase and Abundant Larval Transcript-2 against Challenge in .丝虫抗原谷胱甘肽-S-转移酶和丰富幼虫转录本-2对……攻击的剂量依赖性预防效果
Can J Infect Dis Med Microbiol. 2024 Jul 26;2024:4543922. doi: 10.1155/2024/4543922. eCollection 2024.
9
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?从未接受治疗的比例如何影响消除淋巴丝虫病大规模药物治疗项目的成功?
Clin Infect Dis. 2024 Apr 25;78(Suppl 2):S93-S100. doi: 10.1093/cid/ciae021.
10
How Does Treatment Coverage and Proportion Never Treated Influence the Success of Schistosoma mansoni Elimination as a Public Health Problem by 2030?治疗覆盖率和未接受治疗的比例如何影响到2030年将曼氏血吸虫病作为公共卫生问题消除的成功?
Clin Infect Dis. 2024 Apr 25;78(Suppl 2):S126-S130. doi: 10.1093/cid/ciae074.
Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
印度淋巴丝虫病消除计划的数学模型:群体药物给药的所需持续时间及治疗后感染指标水平
Parasit Vectors. 2016 Sep 13;9(1):501. doi: 10.1186/s13071-016-1768-y.
4
Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.非洲盘尾丝虫病控制计划参与国在消除盘尾丝虫病方面取得的进展:流行病学评估结果
Infect Dis Poverty. 2016 Jun 27;5(1):66. doi: 10.1186/s40249-016-0160-7.
5
Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.被忽视热带病控制项目中驱虫治疗的依从性:一项系统综述
Parasit Vectors. 2016 Jan 27;9:29. doi: 10.1186/s13071-016-1311-1.
6
Global elimination of leprosy by 2020: are we on track?到2020年全球消除麻风病:我们是否在正轨上?
Parasit Vectors. 2015 Oct 22;8:548. doi: 10.1186/s13071-015-1143-4.
7
What impact will the achievement of the current World Health Organisation targets for anthelmintic treatment coverage in children have on the intensity of soil transmitted helminth infections?世界卫生组织目前关于儿童驱虫治疗覆盖率的目标若得以实现,将对土壤传播蠕虫感染的强度产生何种影响?
Parasit Vectors. 2015 Oct 22;8:551. doi: 10.1186/s13071-015-1135-4.
8
Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals.大规模药物管理(MDA)和传播减少后沙眼传播性的可能变化:对2020年全球消除沙眼致盲目标的影响
Parasit Vectors. 2015 Oct 22;8:530. doi: 10.1186/s13071-015-1133-6.
9
Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.用于支持消除宏观寄生虫病淋巴丝虫病管理的模拟模型的贝叶斯校准
Parasit Vectors. 2015 Oct 22;8:522. doi: 10.1186/s13071-015-1132-7.
10
Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo.刚果民主共和国消除人类非洲锥虫病战略的定量评估。
Parasit Vectors. 2015 Oct 22;8:532. doi: 10.1186/s13071-015-1131-8.